Navigation Links
Scientists develop new strategy to overcome drug-resistant childhood cancer
Date:7/11/2012

A new drug combination could offer hope to children with neuroblastoma one of the deadliest forms of childhood cancer by boosting the effectiveness of a promising new gene-targeted treatment.

Researchers at The Institute of Cancer Research in London have found a way to overcome the resistance of cancer cells to a drug called crizotinib, which recently showed positive early results in its first trial in children with cancer.

Crizotinib has already been licensed by the US Food and Drug Administration for use in adult cancers, but early experience suggests tumours eventually stop responding to treatment, after developing additional mutations in the ALK gene targeted by the drug.

The paper, led by The Institute of Cancer Research in collaboration with the Dana-Farber Cancer Institute and Children's Hospital in Boston, publishes this week in the prestigious journal Cancer Cell. The study received funding from a variety of sources including The Neuroblastoma Society, Cancer Research UK, Sparks, the children's medical research charity and The Rooney Foundation.

In the study, scientists detailed their new strategy of combining crizotinib with a second class of drugs mTOR inhibitors to knock out the resistance of cancer cells.

Scientists identified the strategy after revealing for the first time the role played by the ALK cancer-causing gene in driving neuroblastoma, which accounts for 15 per cent of all the UK's childhood cancer deaths.

Neuroblastomas are cancers of the developing nervous system, and new drug combinations are desperately needed as aggressive forms of the disease are very difficult to treat with conventional chemotherapy.

Senior author Dr Louis Chesler, leader of the neuroblastoma drug development team at The Institute of Cancer Research and honorary consultant at The Royal Marsden NHS Foundation Trust, said: "With the first paediatric clinical trial reporting substantial resp
'/>"/>

Contact: ICR Science Communications Manager Jane Bunce
jane.bunce@icr.ac.uk
44-020-715-35106
Institute of Cancer Research
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists solving the mystery of human consciousness
2. Scientists uncover multiple faces of deadly breast cancer
3. Scientists identify major source of cells defense against oxidative stress
4. Scientists tailor cell surface targeting system to hit organelle ZIP codes
5. Scientists rewrite rulebook on breast cancer in landmark global study
6. Warwick scientists uncover how checkpoint proteins bind chromosomes
7. NIH scientists link quickly spreading gene to Asian MRSA epidemic
8. Joslin scientists identify important mechanism that affects the aging process
9. Scripps Research scientists show how memory B cells stay in class to fight different infections
10. Scientists Map Melanomas Genome
11. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Rolling Meadows, Ill. (PRWEB) , ... September 01, ... ... medical procedures done by members of the American Society for Dermatologic Surgery, according ... case. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... is now offering the MonaLisa Touch® , an innovative vaginal health laser ... Touch® is a new hormone-free treatment for atrophic vaginitis, a condition that causes ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding members, ... its inception more than 35 years ago. A pilot program begun by the company ... and, not just those intent on pursuing careers in these fields. The program is ...
(Date:9/1/2015)... ... 2015 , ... WorkCare, Inc., a national occupational health services ... as an Associate Medical Director. , WorkCare specializes in workforce health protection ... abroad. , Dr. Nelson has a diverse background. He trained in sports ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Laboratory Instruments in accordance with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, ... 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, and the appropriate ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2
... or after an ischemic stroke can improve the rate of recovery ... chance of 1.6 times more of // having a favorable recovery ... were on statins after the stroke had the chance of 2.6 ... study had looked into 1618 people who had ischemic stroke to ...
... prepared for the Health And Safety Executive, a UK government ... employees,// researchers had found out that working in shifts can ... during nights, the levels of melatonin, or the sleep hormone, ... new sleep routines. As a result, people do not get ...
... Israel, called Tactile Technologies had developed a robotic dental drill ... easy for the dental surgeon. The drill is all set ... faster, cheaper and less painful than the common manual procedure. ... the artificial tooth, and is generally imbedded in the gum ...
... meats, said the researchers of Cancer Research Center// at the ... to relate meat with pancreatic cancer, but this is the ... growth in the pancreas. Scientist have said that it is ... the meat for long time preservation that causes cancer of ...
... guide to healthy eating that suggests different //food charts for ... diet pattern does not work on everybody, the new diet plan ... new plan is called MyPyramid and it is basically an interactive ... the required information. ,The diet chart works very simply. It ...
... drug streptokinase used in many non-European countries //are not ... present in the preparation is really low. ,The ... medications across the European continent, has found only three ... ,The drug streptokinase is used for its anti-clotting effect ...
Cached Medicine News:
(Date:9/1/2015)... -- Sleep Specialists, LLC a medical device company ... Solutions, a leader in digital health and chronic ... and cost reduction program for patients with Obstructive ... chronic medical condition characterized by periods of interrupted ... risk for cardiovascular disease, hypertension, stroke, congestive heart ...
(Date:9/1/2015)... 1, 2015 Taiwan,s ... conference in Taipei on  August ... Vaucarrin™ platform, a targeted drug delivery technology that uses ... This event was part of a joint press conference held ... Inc. (GNT), showcasing GNT,s latest edible gold-based food and ...
(Date:9/1/2015)... 1, 2015 The global ... basis of sectors, products & services and application. And ... with the increasing demand of advanced drugs for ... propel the growth for bioinformatics market. The implementation ... is known as bioinformatics. Decreasing cost of DNA ...
Breaking Medicine Technology:Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4
... 2012 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today ... The net loss for the first quarter ended ... of $16.0 million during the same period in 2011. The net ... one-time expense of $2.8 million for the purchase of a data ...
... 3, 2012  Gen-Probe Incorporated (NASDAQ: GPRO ) announced ... upcoming investor conferences previously announced on April 26, 2012, and ... conferences: , Deutsche Bank 37th Annual Health Care ... Time;  , Baird,s 2012 Growth Stock Conference in Chicago ...
Cached Medicine Technology:MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 2MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 3MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 4MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 5Gen-Probe Withdraws from Previously Announced Investor Presentations 2
... volume Finnpipette Techpette combines form ... performance pipette. Advanced pipetting technology, ... ensures quality, safety, comfort and ... volume range is an important ...
Inquire...
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 100-1000 Inaccuracy (%) ... Imprecision(%) ... 10 Dimensions: ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
Medicine Products: